{"pageContent": "Objectives: To evaluate the incidence and resolution of sexual adverse experiences (AEs) in men with benign prostatic hyperplasia treated with finasteride 5 mg compared with placebo.", "metaData": {"source": "Five year expanded prostate cancer index composite-based quality of life outcomes after prostatectomy for localized prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/20804482/"}}